杨奎, 周丽平, 张玉, 李涛, 杜昕, 赵雁林, 陈伟. 2015-2021年湖北省耐多药/利福平耐药结核病患者特征及治疗效果影响因素分析[J]. 疾病监测, 2023, 38(5): 561-566. DOI: 10.3784/jbjc.202208120359
引用本文: 杨奎, 周丽平, 张玉, 李涛, 杜昕, 赵雁林, 陈伟. 2015-2021年湖北省耐多药/利福平耐药结核病患者特征及治疗效果影响因素分析[J]. 疾病监测, 2023, 38(5): 561-566. DOI: 10.3784/jbjc.202208120359
Yang Kui, Zhou Liping, Zhang Yu, Li Tao, Du Xin, Zhao Yanlin, Chen Wei. Characteristics of multidrug-resistant /rifampicin-resistant tuberculosis patients and factors associated with treatment effect in Hubei, 2015−2021[J]. Disease Surveillance, 2023, 38(5): 561-566. DOI: 10.3784/jbjc.202208120359
Citation: Yang Kui, Zhou Liping, Zhang Yu, Li Tao, Du Xin, Zhao Yanlin, Chen Wei. Characteristics of multidrug-resistant /rifampicin-resistant tuberculosis patients and factors associated with treatment effect in Hubei, 2015−2021[J]. Disease Surveillance, 2023, 38(5): 561-566. DOI: 10.3784/jbjc.202208120359

2015-2021年湖北省耐多药/利福平耐药结核病患者特征及治疗效果影响因素分析

Characteristics of multidrug-resistant /rifampicin-resistant tuberculosis patients and factors associated with treatment effect in Hubei, 2015−2021

  • 摘要:
      目的  了解湖北省耐多药/利福平耐药结核病患者特征及治疗效果影响因素。
      方法  采用描述性流行病学方法,分析湖北省登记的耐多药/利福平耐药结核病患者特征,利用非条件logistic回归模型分析耐多药/利福平耐药结核病治疗效果的影响因素。
      结果  2015—2021年纳入分析的3799例耐多药/利福平耐药结核病患者,以男性(72.91%)、中青年(84.71%)和农民/民工患者(37.06%)为主。 耐多药/利福平耐药结核病患者治疗成功率为61.30%。 单因素和多因素logistic回归结果均表明男性、年龄≥65岁、复治、职业为农民/民工、未使用阿米卡星/卷曲霉素及治疗时间≤1年患者成功治疗比例较低,且差异均有统计学意义(P<0.05)。
      结论  湖北省耐多药/利福平耐药结核病疫情防控的重点人群为中青年、男性及农民/民工。 为提高湖北省耐多药/利福平耐药结核病患者的治疗效果,治疗时还需对年龄65岁以上的患者、男性和农民/民工人群加大关注力度。 治疗方案中使用二线注射类药物,治疗后重点关注造成治疗时长较短的原因,对提高治疗效果具有一定作用。

     

    Abstract:
      Objective  To analyze the characteristics of multidrug-resistant/rifampicin-resistant tuberculosis(TB) patients and factors assocoated with treatment effect in Hubei province.
      Methods  Descriptive epidemiological method was used to analyze the characteristics of multidrug-resistant/rifampicin-resistant TB patients in Hubei, and unconditional logistic regression model was used to identify the factors associated with the treatment effect of multidrug-resistant/rifampicin-resistant TB.
      Results  From 2015 to 2021, a total of 3799 patients with multidrug-resistant/rifampicin-resistant tuberculosis were included in the analysis, in whom men, middle-aged people and farmers/migrant workers accounted for 72.91%, 84.71% and 37.06% respectively. The treatment success rate in the patients was 61.30%. Both univariate and multivariate logistic regression analysis results showed that the proportion of unsuccessful treatment was higher in men, those aged ≥65 years, retreatment cases, farmers/migrant workers, those using no Amikacin/ Capreomycin and those with treatment duration ≤1 year, and all the difference was statistically significant (P<0.05).
      Conclusion  Young and middle-aged people, men and famers/migrant workers are key population in the prevention and control of multidrug-resistant/rifampicin-resistant TB in Hubei. In the treatment of multidrug/rifampicin-resistant TB patients, more attention should be paid to those aged ≥65 years, men and farmers/migrant workers, the second-line injectable drugs are suggested to use and identifying the reasons causing shorter treatment duration can improve treatment outcomes.

     

/

返回文章
返回